---
search:
  boost: 3
---

# Attention Deficit Hyperactivity Disorder Agents

This is a subcategory of Central Nervous System (CNS) Agents.

## Decision Trees

- [CNS - ADHD - Non-Preferred Products](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUREtYQVlIRDJBS1lZTTZYN1dJQVMxVUtROCQlQCNjPTEkJUAjdD1n){ :target="_blank" rel="noopener"}
- [CNS - ADHD - Preferred Products](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUM0JKQ1pFQTFPMFdGODdZR1pPQ1lMRTVHNyQlQCNjPTEkJUAjdD1n){ :target="_blank" rel="noopener"}
- [CNS - ADHD - Quillivant XR, Methylphenidate Sol, Dextroamphetamine Sol, Dyanavel XR, Procentra](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUMDNKMTVER1YzRFo3WTZVSTRIQjJXRTlKTSQlQCNjPTEkJUAjdD1n){ :target="_blank" rel="noopener"}
- [CNS - ADHD - Qelbree](https://forms.office.com/Pages/ResponsePage.aspx?id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBURVREVUlPMko5RUw4UktHNlY0SExCNU05SCQlQCNjPTEkJUAjdD1n){ :target="_blank" rel="noopener"}

## Formulary

### Preferred

| Preferred                                                                              | Generic Name                                                  | Quantity | Time (Days) |
|:---------------------------------------------------------------------------------------|:--------------------------------------------------------------|:--------:|:-----------:|
| Amphetamine/Dextroamphetamine ER <sup>AR QL</sup>                                      | Amphetamine-Dextroamphetamine ER Cap (all strengths)          |    34    |     34      |
| Amphetamine/Dextroamphetamine IR <sup>AR QL</sup>                                      | Amphetamine-Dextroamphetamine Tab (all strengths excl 30 MG)  |   102    |     34      |
| Amphetamine/Dextroamphetamine IR <sup>AR QL</sup>                                      | Amphetamine-Dextroamphetamine Tab 30 MG                       |    68    |     34      |
| Atomoxetine Cap <sup>AR QL</sup>                                                       | Atomoxetine HCI Cap (all strengths excl 80 MG & 100 MG)       |    68    |     34      |
| Atomoxetine Cap <sup>AR QL</sup>                                                       | Atomoxetine HCI Cap 80 MG & 100 MG                            |    34    |     34      |
| Clonidine ER                                                                           |                                                               |          |             |
| Concerta <sup>AR QL</sup>                                                              | Methylphenidate HCI ER Tab Osmotic (all strengths excl 36 MG) |    34    |     34      |
| Concerta <sup>AR QL</sup>                                                              | Methylphenidate HCI ER Tab Osmotic 36 MG                      |    68    |     34      |
| Dexmethylphenidate Tab <sup>AR QL</sup>                                                | Dexmethylphenidate HCI Tab (all strengths)                    |    68    |     34      |
| Dexmethylphenidate ER (generic of Focalin XR) <sup>AR QL</sup>                         | Dexmethylphenidate HCI ER Cap (all strengths)                 |    34    |     34      |
| Dextroamphetamine ER Cap <sup>AR QL</sup>                                              | Dextroamphetamine Sulfate ER Cap (all strengths excl 15 MG)   |    34    |     34      |
| Dextroamphetamine ER Cap <sup>AR QL</sup>                                              | Dextroamphetamine Sulfate ER Cap 15 MG                        |   136    |     34      |
| Dextroamphetamine IR Tab <sup>AR QL</sup>                                              | Dextroamphetamine Sulfate Tab (all strengths)                 |   102    |     34      |
| Dextroamphetamine Sol <sup>AR</sup>                                                    |                                                               |          |             |
| Dyanavel XR <sup>AR</sup>                                                              |                                                               |          |             |
| Guanfacine ER <sup>QL</sup>                                                            | Guanfacine HCI ER Tab (all strengths)                         |    34    |     34      |
| Methylphenidate ER Cap <sup>AR QL</sup> (generic of Metadate CD, Ritalin LA)           |                                                               |          |             |
| Methylphenidate ER Tab <sup>AR QL</sup> (generic of Concerta, Methylin ER, Ritalin SR) |                                                               |          |             |
| Methylphenidate Sol <sup>AR QL</sup>                                                   | Methylphenidate HCI Soln 5 MG / 5 ML                          |   2040   |     34      |
| Methylphenidate Sol <sup>AR QL</sup>                                                   | Methylphenidate HCI Soln 10 MG / 5 ML                         |   1020   |     34      |
| Methylphenidate Tab <sup>AR QL</sup>                                                   | Methulphenidate HCI Tab (all strengths)                       |    34    |     34      |
| Procentra <sup>AR</sup>                                                                |                                                               |          |             |
| Qelbree <sup>ST</sup>                                                                  |                                                               |          |             |
| Quillichew ER <sup>AR</sup>                                                            |                                                               |          |             |
| Quillivant XR <sup>AR</sup>                                                            |                                                               |          |             |
| Ritalin LA <sup>AR QL</sup>                                                            |                                                               |          |             |
| Vyvanse Cap <sup>QL, [BVG Guidance](https://special-spoon-f542dccd.pages.github.io/Pharmacist%20Reference%20Guide/Medication%20Guidance/vyvanse/?h=vyvan)</sup>                                                              | Lisdexamfetamine Dimesylate Cap (all strengths)               |    34    |     34      |

### Non-Preferred

| Non-Preferred                                                         | Generic Name                                                 |         Quantity          |        Time (Days)        |
|:----------------------------------------------------------------------|:-------------------------------------------------------------|:-------------------------:|:-------------------------:|
| Adhansia XR <sup>AR</sup>                                             |                                                              |                           |                           |
| Adzenys ER                                                            |                                                              |                           |                           |
| Adzenys XR ODT                                                        |                                                              |                           |                           |
| Amphetamine Tab                                                       |                                                              |                           |                           |
| Azstarys <sup>AR</sup>                                                |                                                              |                           |                           |
| Cotempla XR ODT <sup>AR</sup>                                         |                                                              |                           |                           |
| Daytrana <sup>AR BvG ==(Process by NDC)==</sup>                                            |                                                              |                           |                           |
| Evekeo ODT                                                            |                                                              |                           |                           |
| Jornay PM <sup>AR</sup>                                               |                                                              |                           |                           |
| Methamphetamine                                                       |                                                              |                           |                           |
| Methylphenidate Chewable Tab <sup>AR QL</sup>                         | Methylphenidate HCI Chew Tab (all strengths)                 | Determined pursuant to PA | Determined pursuant to PA |
| Methylphenidate ER <sup>AR QL</sup>(generic of Aptensio XR, Relexxii) |                                                              |                           |                           |
| Mydayis <sup>QL</sup>                                                 | Amphetamin / Dextroamphetamine 3-Bead ER Cap (all strengths) | Determined pursuant to PA | Determined pursuant to PA |
| Vyvanse Chewable Tab                                                  |                                                              |                           |                           |
| Xelstrym <sup>AR</sup>                                                |                                                              |                           |                           |
| Zenzedi <sup>AR QL</sup>                                              | Dextroamphetamine Sulfate Tab (all strengths)                | Determined pursuant to PA | Determined pursuant to PA |

## Authorizations

**Length of Authorizations**: 365 Days

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Step Therapy

Step Therapy Criteria

- Must have had an inadequate clinical response of at least ^^30 days^^ with atomoxetine **OR** at least ^^two preferred^^ stimulants

### Non-Preferred

Non-Preferred Criteria

- Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    - For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
- Must have had an inadequate clinical response of at least ^^30 days^^ with at least ^^three preferred^^ drugs
    - For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    - For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

### Additional Information

- Requests for non-preferred immediate-release formulations must have all required trials with preferred immediate-release drugs, and requests for non-preferred extended-release formulations must have all required trials with preferred extended-release drugs
- For patients established on drugs that change from preferred to non-preferred on January 1, a prior authorization is **NOT** required until **after** June 30th of that year.**

[**ADHD Approval language for Non-Preferred Meds due transition of care/COT](https://special-spoon-f542dccd.pages.github.io/Pharmacist%20Reference%20Guide/Medication%20Guidance/ADHD/)

### Subsequent Authorization

Subsequent Authorization Criteria

- Must provide documentation of patient's clinical response to treatment and ongoing safety monitoring

**AR** - Adderall, Dexedrine, & Zenzedi IR: a PA is required for patients younger than 3 years </br>
**AR** - Adderall XR, Atomoxetine, Cotempla XR-ODT, Daytrana, Dexedrine ER, Dexmethylphenidate, Methylphenidate IR & ER, Quillichew ER, and Xelstrym: a PA is required for patients younger than 6 years </br>
**AR** - Dextroamphetamine Solution & Dyanavel XR: a PA is required for patients 12 years and older </br>
**AR** - Methylphenidate Solution/Suspension: a PA is required for patients younger than 6 years and 12 years and older

## Links

[Denial Language (Rph Use Only: Technicians CANNOT deny Prior Authorizations)](https://mygainwell-my.sharepoint.com.mcas.ms/:w:/r/personal/rachel_carpenter_gainwelltechnologies_com/_layouts/15/Doc.aspx?sourcedoc=%7BE78364D9-082C-41C5-9902-8F8AC94900ED%7D&file=Denial%20Language%20Updated%2002062023.docx&mobileredirect=true&action=embedview&wdStartOn=27&cid=f4472ece-6d4f-4694-b0c5-c150a2f53fea){:target="_blank" rel="noopener"} </br>
[Criteria](https://medicaid.ohio.gov/static/PHM/drug-coverage/20230701+UPDL+Criteria+_v1_FINAL.approved.pdf#page=35){ :target="_blank" rel="noopener"} </br>
[Preferred Drug List](https://medicaid.ohio.gov/static/PHM/drug-coverage/20230701_UPDL_FINAL_ODM.approved.v2.pdf#page=15){ :target="_blank" rel="noopener"} </br>
[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf){ :target="_blank" rel="noopener"}
